Description

This lecture showcases the research activities of three early-career transfusion medicine and cellular therapies investigators who are utilizing or have utilized NBF grant funding to develop their investigations into highly productive transfusion medicine, cellular therapies or patient blood management research programs. The NBF Award for Innovative Research will be awarded at this luncheon to a previous NBF grant recipient who has developed his/her studies into high-profile innovative research with substantial impact that may ultimately lead to improving patient outcomes. Enjoy a delicious lunch while the scientists discuss their latest research with a focus on the role their findings will play in driving the future of transfusion medicine, cellular therapies and patient blood management. Time for questions and informal discussion will be provided. 

This session is supported by an unrestricted educational grant from TerumoBCT.

Please note: Francesca Vinchi, PhD did not consent to be recorded; therefore, the on-demand presentation and handout have been modified accordingly.

Learning Objectives:

• Discover how the NBF Scientific Research Grants Program has advanced original research for early-career investigators in the areas of blood banking, transfusion medicine, cellular therapies and patient blood management
• Assess and appreciate how NBF-funded exploratory research activities have driven developments that improve patient and donor care
• Appreciate cutting-edge discoveries that will shape transfusion medicine, cellular therapies and patient blood management in the future

Speaker(s):

• Dr. Krystalyn E. Hudson, Ph.D, Assistant Professor, Department of Pathology and Cell Biology, Columbia University Medical Center
• Dr. Neil Blumberg, MD, Transfusion Medicine, University of Rochester Medical Center
• Dr. Francesca Vinchi, PhD, New York Blood Center

Disclosures

• Neil Blumberg, MD : <p>CSL Plasma: Consultant</p>
• Krystalyn Hudson, Ph.D : <p>Nothing to Disclose</p>
• Francesca Vinchi, PhD : <p><strong>Novartis:</strong> Grant/Research Support (Secondary Investigators need not disclose)  I  <strong>Vifor Pharma</strong>: Grant/Research Support (Secondary Investigators need not disclose)  I  <strong>Silence Therapeutics</strong>: Consultant</p>